Angela Keightley Email

VP, Assay Development . BlueRock Therapeutics

Current Roles

Employees:
675
Revenue:
$104.6M
About
BlueRock Therapeutics is a next-generation regenerative medicine company focused on breakthrough stem cell technology treatments of cardiovascular and neurodegenerative diseases. BlueRock Therapeutics has launched with the backing of a combined $225 million investment by Bayer and biotechnology investment firm Versant Ventures. BlueRock’s initial programs will focus on induced pluripotent stem cell (iPSC)-derived therapeutics to expand their technology pipeline.
BlueRock Therapeutics Address
238 Main Street
Cambridge, MA
United States
BlueRock Therapeutics Email